EDURANT: payments to doctors
Payments that named EDURANT as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $79K
- Providers
- 47
- Transactions
- 179
- Average per transaction
- $440
The per-transaction average — $440 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 47 providers the average total is $1,675, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Janssen Scientific Affairs, LLC | $77,882 | 99.0% |
| Biosense Webster, Inc. | $727 | 0.9% |
| Janssen Research & Development, LLC | $78 | 0.1% |
| Johnson & Johnson Surgical Vision, Inc. | $19 | 0.0% |